| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |